By using this site, you agree to the Privacy Policy and Terms of Use.
Accept
Gulf PressGulf Press
  • Home
  • Gulf News
    • Saudi Arabia
    • UAE24/7
    • Kuwait
    • Qatar
    • Bahrain
    • Oman
  • World
  • Business
    • Market DataLive
    • Finance
    • Economy
    • Energy
    • Crypto
    • ForexHot
    • Tech
  • Sports
  • Lifestyle
  • Videos
Search
Countries
  • Saudi Arabia
  • UAE
  • Kuwait
  • Qatar
  • Bahrain
  • Oman
More Topics
  • Technology
  • Health
  • Entertainment
  • Crypto
  • Forex
  • Stocks
Site Links
  • Business Hub
  • Trending
  • Weather
  • Customize Interests
  • Bookmarks
  • Newsletter
  • Terms
  • Press Release
  • Advertise
  • Contact
© 2023 Gulf Press. All Rights Reserved.
Reading: Can Semaglutide Drugs Reduce the Incidence of Alcohol Use Disorder?
Share
Notification Show More
Recent Saved
Workers in Bucharest face challenges as temperatures rise
World
Dress code guidelines for the Qatari government sector during office hours
Qatar
Court rules in favor of worker after company dismisses him for salary deductions over 6 years, awarding BD 27,000.
Bahrain
UAE to See Almost 30,000 New Millionaires in 5 Years
UAE
Proposed New Labor Law in Bahrain Targets Increasing Job Opportunities
Bahrain
Latest News
UAE Ranks Among Top Rugby Markets on TOD as British & Irish Lions Tour Kicks Off
Sports
Darven: A New Leap in AI-Powered Legal Technology Launching from the UAE to the World
Tech
Beat the Heat This Summer with a Chill Out on Dubai Marina
World
Historic Italian City of Assisi to Host International Exhibition “Jordan: Dawn of Christianity”
World
Jordan to Host Iraq in the Final Round of the Asian World Cup Qualifiers After Securing Historic Spot
Sports
The Myriad Redefines Student Living for a Mobile, Urban Generation
UAE
L’Oréal Paris Welcomes Yasmine Sabri as New Brand Ambassador for the Middle East
Lifestyle
Roland Garros 2025: A New Era of Viewing, A Tribute to Legends, and Moments to Remember
Sports World
Bitget Celebrates Bitcoin Pizza Day by Distributing Over 5000 Pizzas in Over 20 Cities Worldwide
Crypto
Bitget Protection Fund Maintains Strength with $561 Million Average Value in April 2025
Business Crypto
Aa
Gulf PressGulf Press
Aa
  • Gulf News
  • World
  • Business
  • Entertainment
  • Lifestyle
  • Sports
  • Videos
Search
  • Home
    • Videos
    • Business Hub
    • Trending
  • Gulf
    • Saudi Arabia
    • UAE
    • Kuwait
    • Qatar
    • Bahrain
    • Oman
  • Business
    • Market Data
    • Crypto
    • Economy
    • Energy
    • Finance
    • Forex
    • Tech
  • More News
    • World
    • Lifestyle
    • Entertainment
    • Sports
Have an existing account? Sign In
Follow US
  • Terms
  • Press Release
  • Advertise
  • Contact
© 2023 Gulf Press. All Rights Reserved.
Gulf Press > Health > Can Semaglutide Drugs Reduce the Incidence of Alcohol Use Disorder?
Health

Can Semaglutide Drugs Reduce the Incidence of Alcohol Use Disorder?

News Room
Last updated: 2024/06/05 at 10:22 AM
News Room
Share
4 Min Read
SHARE

A recent study from Case Western Reserve University School of Medicine has revealed that Wegovy and Ozempic, popular diabetes and weight-loss drugs, may have the potential to significantly reduce alcohol misuse and alcohol use disorder. The active ingredient in these medications, semaglutide, has shown promise as a new treatment for alcohol-use disorder, a condition responsible for a high number of deaths annually in the United States. Despite the promising findings, experts agree that further clinical trials are necessary to confirm semaglutide’s effectiveness in preventing or treating alcohol use disorder.

Alcohol use disorder, also known as alcohol misuse, dependence, and addiction, is a serious medical condition characterized by the persistent consumption of alcohol despite negative consequences. The severity of alcohol use disorder can vary, ranging from mild to moderate to severe, and can have a detrimental impact on an individual’s health, quality of life, and relationships. The harmful effects of alcohol misuse include injuries, chronic diseases, various cancers, risky behaviors, absenteeism, and negative pregnancy outcomes.

Factors that can increase the likelihood of developing alcohol use disorder include a family history of alcohol misuse, mental health issues, and early initiation of alcohol consumption. Currently, the FDA has approved three medications, naltrexone, acamprosate, and disulfiram, for the treatment of alcohol use disorder. However, a new study published in Nature Communications suggests that drugs containing semaglutide may offer a potential new treatment option for excessive alcohol consumption and alcohol use disorder.

Semaglutide, the active ingredient in Wegovy and Ozempic, is a type of medication known as a glucagon-like peptide-1 receptor agonist (GLP-1). GLP-1 agonists are effective in regulating blood sugar levels in type 2 diabetes and reducing appetite. The recent study analyzing the health records of individuals with obesity revealed that those treated with semaglutide experienced a significant reduction in the onset and recurrence of alcohol use disorder compared to those treated with other anti-obesity medications. Further research is necessary to confirm the clinical use of semaglutide for alcohol use disorder.

Rong Xu, PhD, the lead researcher of the study, highlighted the potential benefits of semaglutide for alcohol use disorder based on real-world evidence gathered from the study. Researchers observed a decrease in suicidal ideation among participants taking semaglutide, contrary to previous concerns. Additionally, semaglutide was associated with a reduction in both new cases and recurrences of cannabis-use disorder, further emphasizing its potential benefits. While these findings are promising, further randomized clinical trials are needed to confirm semaglutide’s efficacy for alcohol use disorder.

Medical experts not involved in the study, such as Mark A. Anton, MD, and Sazan Sylejmani, PharmD, found the research results to be promising and aligned with their observations in clinical practice. Both Anton and Sylejmani emphasized the potential of GLP-1 receptor agonists like Wegovy and Ozempic in reducing alcohol abuse and dependence, as reported by patients using these medications. The findings of the study support the need for future randomized clinical trials to test semaglutide for alcohol use disorders, with potential implications for integrated treatment strategies addressing metabolic and behavioral health issues concurrently.

Sign Up For Daily Newsletter

Be keep up! Get the latest breaking news delivered straight to your inbox.
I have read and agree to the terms & conditions
By signing up, you agree to our Terms of Use and acknowledge the data practices in our Privacy Policy. You may unsubscribe at any time.
News Room June 5, 2024
Share this Article
Facebook Twitter Copy Link Print
Previous Article Two Emirati students’ original music to be broadcasted at the International Space Station – News
Next Article Bangladesh and Bahrain mark half a century of diplomatic relations
Leave a comment Leave a comment

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Stay Connected

235.3k Followers Like
69.1k Followers Follow
56.4k Followers Follow
136k Subscribers Subscribe
- Advertisement -
Ad imageAd image

Latest News

UAE Ranks Among Top Rugby Markets on TOD as British & Irish Lions Tour Kicks Off
Sports July 6, 2025
Darven: A New Leap in AI-Powered Legal Technology Launching from the UAE to the World
Tech July 1, 2025
Beat the Heat This Summer with a Chill Out on Dubai Marina
World July 1, 2025
Historic Italian City of Assisi to Host International Exhibition “Jordan: Dawn of Christianity”
World June 28, 2025

You Might also Like

Health

Mindfulness could be equally effective as antidepressants

October 17, 2024
Health

What is the impact of caffeine on the risk of developing diseases?

October 17, 2024
Health

Scientists discover combination of 14 genes that enhance outcomes

October 16, 2024
Health

Seizure medication demonstrates potential in individuals with no genetic risk

October 16, 2024
Health

Heart disease increases risk, heparin can postpone onset

October 16, 2024
Health

What type of breakfast is most effective for weight loss in women compared to men?

October 15, 2024
Health

How does the brain remove “waste” to protect itself?

October 14, 2024
Health

How does stress, sleep, and gut imbalances affect it?

October 13, 2024
//

Gulf Press is your one-stop website for the latest news and updates about Arabian Gulf and the world, follow us now to get the news that matters to you.

Quick Link

  • Privacy Policy
  • Terms of ue
  • Advertise
  • Contact

How Topics

  • Gulf News
  • International
  • Business
  • Lifestyle

Sign Up for Our Newsletter

Subscribe to our newsletter to get our latest news instantly!

I have read and agree to the terms & conditions
Gulf PressGulf Press
Follow US

© 2023 Gulf Press. All Rights Reserved.

Join Us!

Subscribe to our newsletter and never miss our latest news, podcasts etc..

I have read and agree to the terms & conditions
Zero spam, Unsubscribe at any time.

Removed from reading list

Undo
Welcome Back!

Sign in to your account

Lost your password?